BamSEC and AlphaSense Join Forces
Learn More

Kyntra Bio Inc. – Material Contracts

NASDAQ: KYNB    
Share price (8/12/26): $7.10    
Market cap (8/12/26): $28.7 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 5 pages Kyntra Bio, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.23
from 10-K 11 pages Kyntra Bio, Inc. Change in Control and Severance Agreement
12/34/56
EX-10.15
from 10-K 14 pages Indemnity Agreement
12/34/56
EX-10.6
from 10-K 4 pages [Date] via Docusign
12/34/56
EX-10.5
from 10-K 9 pages Name Change Approved by Board On: December 19, 2025
12/34/56
EX-10.3
from 10-K 13 pages Kyntra Bio, Inc. 2014 Employee Stock Purchase Plan Adopted by the Board of Directors: September 09, 2014 Approved by the Stockholders: September 30, 2014 Name Change Approved by Board On: December 19, 2025
12/34/56
EX-10.2
from 10-K 62 pages Kyntra Bio, Inc. 2014 Equity Incentive Plan Adopted by the Board of Directors: September 09, 2014 Approved by the Stockholders: September 30, 2014 Ipo Date/Effective Date: November 14, 2014 Name Change Approved by Board On: December 19, 2025
12/34/56
EX-10.1(III)
from 10-K 13 pages Kyntra Bio, Inc. Stock Option Grant Notice (2024 Equity Incentive Plan) Name Change Approved by Board On: December 19, 2025
12/34/56
EX-10.1(II)
from 10-K 10 pages Kyntra Bio, Inc. Restricted Stock Unit Grant Notice (2024 Equity Incentive Plan) Name Change Approved by Board On: December 19, 2025
12/34/56
EX-10.1
from 10-K 28 pages Kyntra Bio, Inc. 2024 Equity Incentive Plan Adopted by the Board of Directors: April 22, 2024 Approved by the Stockholders: June 5, 2024 Name Change Approved by Board On: December 19, 2025
12/34/56
EX-10.3
from 10-Q 11 pages Amendment to the Share Purchase Agreement
12/34/56
EX-10.2
from 10-Q 26 pages Termination Agreement by and Between Fibrogen, Inc. and Astrazeneca Ab Dated as of February 25, 2024, as Amended and Restated on August 29, 2025
12/34/56
EX-10.1
from 10-Q 5 pages Amendment No. 2 to Second Amended and Restated Exclusive License Agreement
12/34/56
EX-10.1
from 8-K 7 pages Fourth Amendment to Financing Agreement
12/34/56
EX-10.1
from 10-Q 4 pages Amendment No. 2 to Collaboration Agreement
12/34/56
EX-10.1
from 8-K 7 pages Third Amendment to Financing Agreement
12/34/56
EX-10.1
from 8-K 7 pages Second Amendment to Financing Agreement
12/34/56
EX-10.4
from 10-Q 6 pages First Amendment to Financing Agreement
12/34/56
EX-10.3
from 10-Q 3 pages Amendment No. 1 to the First Amended and Restated Option Agreement and Plan of Merger
12/34/56
EX-10.2
from 10-Q 3 pages Amendment No. 1 to the First Amended and Restated Evaluation Agreement
12/34/56